In a major development that could bring relief to thousands of patients across India, the central government is preparing to slash prices of critical and life-saving medicines, particularly those used to treat cancer, HIV, and rare genetic disorders. A recently accessed official document reveals that an interdepartmental committee has recommended a set of sweeping customs duty exemptions and concessions aimed at making high-cost medical treatments more accessible to Indian patients.